Cross-source evidence timeline
Teduglutide research timeline
Follow 58 selected, directly cited source records from May 7, 2012 through September 8, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Clinical trials
ClinicalTrials.gov record NCT06973304↗
PeptideScanner retained ClinicalTrials.gov record NCT06973304 at 2026-11-15T21:55:23.600Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study.↗
PubMed lists PMID 41647102 in Intestinal Failure (New York, N.Y.) as Journal Article, with publication-date metadata of 2024-11-28 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 28, 2024 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Teduglutide in pediatric intestinal failure: A position statement of the Italian society of pediatric gastroenterology, hepatology and nutrition (SIGENP).↗
PubMed lists PMID 35654733 in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver as Journal Article, Review, Consensus Statement, with publication-date metadata of 2022-05-31 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 31, 2022 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy.↗
PubMed lists PMID 36177820 in Revista espanola de enfermedades digestivas as Case Reports, Journal Article, with publication-date metadata of 2023-06 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: June 2023 · month precisionAdded to PeptideScanner November 15, 2026Literature metadata
Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.↗
PubMed lists PMID 37001195 in Clinical nutrition (Edinburgh, Scotland) as Journal Article, with publication-date metadata of 2023-03-18 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 18, 2023 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.↗
PubMed lists PMID 37270288 in The American journal of clinical nutrition as Journal Article, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 3, 2023 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2025
Literature metadata
Quality of life and lived experience of patients with short bowel syndrome treated with teduglutide and weaning off home parenteral nutrition: a qualitative analysis of patient diaries.↗
PubMed lists PMID 40764045 in BMJ open gastroenterology as Journal Article, with publication-date metadata of 2025-08-05 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 5, 2025 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03562130↗
PeptideScanner retained ClinicalTrials.gov record NCT03562130 at 2026-11-15T21:55:23.600Z. Its registry update date was 2025-09-11, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Teduglutide treatment during breast feeding in a patient with intestinal failure: a case report.↗
PubMed lists PMID 40771220 in Frontiers in nutrition as Case Reports, Journal Article, with publication-date metadata of 2025-07-23 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 23, 2025 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Short bowel syndrome and d-lactic acidosis: A case report with supplemental home parenteral nutrition and teduglutide.↗
PubMed lists PMID 40086997 in Endocrinologia, diabetes y nutricion as Case Reports, Journal Article, Review, with publication-date metadata of 2025-03 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 2025 · month precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT02949362↗
PeptideScanner retained ClinicalTrials.gov record NCT02949362 at 2026-11-15T21:55:23.600Z. Its registry update date was 2025-03-19, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.↗
PubMed lists PMID 39125394 in Nutrients as Journal Article, Multicenter Study, Observational Study, with publication-date metadata of 2024-08-01 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 1, 2024 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2024
Literature metadata
Management Patterns of Teduglutide Use in Short Bowel Syndrome: A Survey of 70 Healthcare Professionals.↗
PubMed lists PMID 39519595 in Nutrients as Journal Article, with publication-date metadata of 2024-11-01 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 1, 2024 · day precisionAdded to PeptideScanner November 15, 2026Regulatory
Federal Register notice 2024-16618↗
The Federal Register published notice 2024-16618, attributed to FDA and its parent HHS department, on 2024-07-29. Its official title is “Pediatric Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT05027308↗
PeptideScanner retained ClinicalTrials.gov record NCT05027308 at 2026-11-15T21:55:23.600Z. Its registry update date was 2024-05-16, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026
Source year
2023
Clinical trials
ClinicalTrials.gov record NCT04290429↗
PeptideScanner retained ClinicalTrials.gov record NCT04290429 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-11-29, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells.↗
PubMed lists PMID 37646058 in Advanced pharmaceutical bulletin as Journal Article, with publication-date metadata of 2022-12-06 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 6, 2022 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Teduglutide for the treatment of short bowel syndrome: a double-edged sword?↗
PubMed lists PMID 37270286 in The American journal of clinical nutrition as Editorial, Comment, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 3, 2023 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.↗
PubMed lists PMID 37270289 in The American journal of clinical nutrition as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-05-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 3, 2023 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT02431325↗
PeptideScanner retained ClinicalTrials.gov record NCT02431325 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-06-12, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03596164↗
PeptideScanner retained ClinicalTrials.gov record NCT03596164 at 2026-11-15T21:55:23.600Z. Its registry update date was 2023-03-15, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026
Source year
2022
Clinical trials
ClinicalTrials.gov record NCT04465396↗
PeptideScanner retained ClinicalTrials.gov record NCT04465396 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-10-04, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03422666↗
PeptideScanner retained ClinicalTrials.gov record NCT03422666 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-06-14, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03442972↗
PeptideScanner retained ClinicalTrials.gov record NCT03442972 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-05-25, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03268811↗
PeptideScanner retained ClinicalTrials.gov record NCT03268811 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-05-24, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Hernia enlargement and pancreatitis in a patient with short bowel syndrome treated with teduglutide.↗
PubMed lists PMID 34903028 in Nutricion hospitalaria as Case Reports, Journal Article, with publication-date metadata of 2022-02-09 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: February 9, 2022 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT02980666↗
PeptideScanner retained ClinicalTrials.gov record NCT02980666 at 2026-11-15T21:55:23.600Z. Its registry update date was 2022-02-02, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026
Source year
2021
Clinical trials
ClinicalTrials.gov record NCT02889393↗
PeptideScanner retained ClinicalTrials.gov record NCT02889393 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-10-06, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03716115↗
PeptideScanner retained ClinicalTrials.gov record NCT03716115 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-09-27, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.↗
PubMed lists PMID 31522784 in Clinical nutrition (Edinburgh, Scotland) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-08-23 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 23, 2019 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Teduglutide Therapy in 2 Patients With Short-Bowel Syndrome and Familial Adenomatous Polyposis.↗
PubMed lists PMID 32829492 in JPEN. Journal of parenteral and enteral nutrition as Case Reports, Journal Article, with publication-date metadata of 2020-09-07 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 7, 2020 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Comprehensive nutritional assessment in short bowel syndrome with chronic renal failure on teduglutide therapy: A case report.↗
PubMed lists PMID 32088500 in Nutrition (Burbank, Los Angeles County, Calif.) as Case Reports, Journal Article, with publication-date metadata of 2020-01-07 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 7, 2020 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00930644↗
PeptideScanner retained ClinicalTrials.gov record NCT00930644 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-11, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT01560403↗
PeptideScanner retained ClinicalTrials.gov record NCT01560403 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-10, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00081458↗
PeptideScanner retained ClinicalTrials.gov record NCT00081458 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT01952080↗
PeptideScanner retained ClinicalTrials.gov record NCT01952080 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT02340819↗
PeptideScanner retained ClinicalTrials.gov record NCT02340819 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-09, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT01209351↗
PeptideScanner retained ClinicalTrials.gov record NCT01209351 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-04, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00798967↗
PeptideScanner retained ClinicalTrials.gov record NCT00798967 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-03, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00172185↗
PeptideScanner retained ClinicalTrials.gov record NCT00172185 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-06-02, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00072839↗
PeptideScanner retained ClinicalTrials.gov record NCT00072839 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-25, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.↗
PubMed lists PMID 32804906 in Journal of pediatric gastroenterology and nutrition as Journal Article, with publication-date metadata of 2020-12 (month precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: December 2020 · month precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00308438↗
PeptideScanner retained ClinicalTrials.gov record NCT00308438 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-14, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT00819468↗
PeptideScanner retained ClinicalTrials.gov record NCT00819468 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-14, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03571516↗
PeptideScanner retained ClinicalTrials.gov record NCT03571516 at 2026-11-15T21:55:23.600Z. Its registry update date was 2021-05-11, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.↗
PubMed lists PMID 31423614 in JPEN. Journal of parenteral and enteral nutrition as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-08-18 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 18, 2019 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2020
Literature metadata
Teduglutide for short bowel syndrome.↗
PubMed lists PMID 32346219 in Australian prescriber as Journal Article, Review, with publication-date metadata of 2020-03-03 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 3, 2020 · day precisionAdded to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT03663582↗
PeptideScanner retained ClinicalTrials.gov record NCT03663582 at 2026-11-15T21:55:23.600Z. Its registry update date was 2020-08-04, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Literature metadata
Accelerated Colorectal Polyposis in an Immunosuppressed Patient With a Small Bowel Transplant Treated With Teduglutide: Case Report and Review of Literature.↗
PubMed lists PMID 31176580 in Clinical colorectal cancer as Case Reports, Journal Article, Review, with publication-date metadata of 2019-03-11 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 11, 2019 · day precisionAdded to PeptideScanner November 15, 2026Literature metadata
Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome.↗
PubMed lists PMID 30990222 in Inflammatory bowel diseases as Case Reports, Letter, with publication-date metadata of 2019-08-20 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 20, 2019 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2019
Literature metadata
Teduglutide for the Treatment of Short Bowel Syndrome.↗
PubMed lists PMID 24871569 in The Annals of pharmacotherapy as Review, Journal Article, with publication-date metadata of 2014-05-28 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 28, 2014 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2018
Literature metadata
Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of Teduglutide.↗
PubMed lists PMID 27507402 in JPEN. Journal of parenteral and enteral nutrition as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-08-09 (day precision). PeptideScanner associated the retained record with the identity slug teduglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 9, 2016 · day precisionAdded to PeptideScanner November 15, 2026
Source year
2016
Clinical trials
ClinicalTrials.gov record NCT02099084↗
PeptideScanner retained ClinicalTrials.gov record NCT02099084 at 2026-11-15T21:55:23.600Z. Its registry update date was 2016-02-22, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026
Source year
2015
Regulatory
Federal Register notice 2015-11000↗
The Federal Register published notice 2015-11000, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GATTEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.↗
Added to PeptideScanner November 15, 2026
Source year
2012
Regulatory
Drugs@FDA application NDA203441↗
The official Drugs@FDA dataset lists original submission 1 for NDA 203441 with status AP dated 2012-12-21, and names teduglutide among the application record's active ingredients.↗
Added to PeptideScanner November 15, 2026Regulatory
Federal Register notice 2012-20612↗
The Federal Register published notice 2012-20612, attributed to FDA and its parent HHS department, on 2012-08-22. Its official title is “Gastrointestinal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT01028768↗
PeptideScanner retained ClinicalTrials.gov record NCT01028768 at 2026-11-15T21:55:23.600Z. Its registry update date was 2012-05-07, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026Clinical trials
ClinicalTrials.gov record NCT01028924↗
PeptideScanner retained ClinicalTrials.gov record NCT01028924 at 2026-11-15T21:55:23.600Z. Its registry update date was 2012-05-07, and PeptideScanner's reviewed identity mapping was teduglutide.↗
Added to PeptideScanner November 15, 2026